Round Type
Venture
Description
Spine BioPharma, LLC, a company committed to developing non-opiate, non-surgical therapies for the treatment of pain and disability from chronic low back pain caused by degenerative disc disease, today announced a $3 million investment by Pacira Biosciences in the form of a convertible note. The investment will support the further development of Remedisc, a first-in-class therapeutic for the treatment of degenerative disc disease. Pacira will make an additional $7 million investment predicated upon achieving certain prespecified milestones.
Quick answer
Spine BioPharma raised an undisclosed amount in a funding round, dated April 20, 2021. Spine BioPharma is based in New York, New York, United States.
- How much did Spine BioPharma raise?
- Spine BioPharma raised an undisclosed amount in a funding round on April 20, 2021.
- What does Spine BioPharma do?
- Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction.
- Where is Spine BioPharma based and how big is it?
- Spine BioPharma is based in New York, New York, United States.
- Who are the decision-makers at Spine BioPharma?
- Fundz holds 2 contacts at Spine BioPharma, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Spine BioPharma that raised within 45 days of this round, from Fundz verified event records.
- Myra Vision raised $17M (Series A) on June 1, 2021.
- Restor3D raised $13M on May 28, 2021.
- Climb Bio, Inc. raised $60M on May 28, 2021.
- Acuitive Technologies raised $855K (Seed) on May 26, 2021.
- Axial Therapeutics raised $4.8M (Seed) on May 26, 2021.
- Sparrow Pharmaceuticals raised $50M (Series A) on May 18, 2021.
Who to call at Spine BioPharma, and when
A new round usually means Spine BioPharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Spine BioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spine BioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spine BioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spine BioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Spine BioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.